FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) reports its financial results for the three months and nine months ended September 30, 2007. Revenue for the three months ended September 30, 2007 increased to $6,343,000 compared with $1,701,000 for the three months ended September 30, 2006. Revenue for the nine months ended September 30, 2007 increased to $17,390,000 compared with $2,644,000 for the nine months ended September 30, 2006. Revenue from Fortical sales and royalties was $5,771,000 and $13,607,000, respectively, for the three months and nine months ended September 30, 2007.
